181 related articles for article (PubMed ID: 28428962)
1. A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos.
Labarta E; Bosch E; Mercader A; Alamá P; Mateu E; Pellicer A
Biomed Res Int; 2017; 2017():5637923. PubMed ID: 28428962
[TBL] [Abstract][Full Text] [Related]
2. No effect of ovarian stimulation and oocyte yield on euploidy and live birth rates: an analysis of 12 298 trophectoderm biopsies.
Irani M; Canon C; Robles A; Maddy B; Gunnala V; Qin X; Zhang C; Xu K; Rosenwaks Z
Hum Reprod; 2020 May; 35(5):1082-1089. PubMed ID: 32348476
[TBL] [Abstract][Full Text] [Related]
3. Controlled ovarian hyperstimulation (COH) parameters associated with euploidy rates in donor oocytes.
McCulloh DH; Alikani M; Norian J; Kolb B; Arbones JM; Munné S
Eur J Med Genet; 2019 Aug; 62(8):103707. PubMed ID: 31252058
[TBL] [Abstract][Full Text] [Related]
4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
6. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.
Sekhon L; Shaia K; Santistevan A; Cohn KH; Lee JA; Beim PY; Copperman AB
J Assist Reprod Genet; 2017 Jun; 34(6):749-758. PubMed ID: 28321529
[TBL] [Abstract][Full Text] [Related]
7. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
[TBL] [Abstract][Full Text] [Related]
8. The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing.
Chamayou S; Sicali M; Alecci C; Ragolia C; Liprino A; Nibali D; Storaci G; Cardea A; Guglielmino A
J Assist Reprod Genet; 2017 Apr; 34(4):479-486. PubMed ID: 28070710
[TBL] [Abstract][Full Text] [Related]
9. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
11. Changing ovarian stimulation parameters in a subsequent cycle does not increase the number of euploid embryos.
Hodes-Wertz B; McCulloh DH; Berkeley AS; Grifo JA
Fertil Steril; 2015 Apr; 103(4):947-53. PubMed ID: 25707340
[TBL] [Abstract][Full Text] [Related]
12. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?
Berkkanoglu M; Ozgur K
Fertil Steril; 2010 Jul; 94(2):662-5. PubMed ID: 19368912
[TBL] [Abstract][Full Text] [Related]
13. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
[TBL] [Abstract][Full Text] [Related]
15. Euploid rates among oocyte donors: is there an optimal age for donation?
Hoyos LR; Cheng CY; Brennan K; Hubert G; Wang B; Buyalos RP; Quinn M; Shamonki M
J Assist Reprod Genet; 2020 Mar; 37(3):589-594. PubMed ID: 31955339
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Number of Euploid Embryos in Preimplantation Genetic Testing Cycles With Early-Follicular Phase Long-Acting Gonadotropin-Releasing Hormone Agonist Long Protocol.
Li G; Wu Y; Niu W; Xu J; Hu L; Shi H; Sun Y
Front Endocrinol (Lausanne); 2020; 11():424. PubMed ID: 32793112
[TBL] [Abstract][Full Text] [Related]
17. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
[TBL] [Abstract][Full Text] [Related]
20. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
